PROVEO is a partnership between three companies with extensive experience in all aspects of ADCs.
Strategically formed in 2015, PROVEO is a three-company collaboration providing complete and efficient solutions to the market for the process development and manufacture of antibody drug conjugates (ADCs).                
Through this collaboration, AGC Biologics provides monoclonal antibody production, and Cerbios performs process development, manufacture of the cytotoxic drug-linker payload, and the conjugation services of the ADC drug substance. Oncotec provides aseptic fill and lyophilization of the ADC drug product, supply chain, and secondary packaging through to ready-to-deliver final drug product. This global collaboration reaches from Seattle, Washington, to Copenhagen, Denmark to Lugano,  Switzerland. 



There are two parts to the Festival of Biologics: four conferences covering Antibodies, Immunotherapy, Biosimilars and Clinical Trials and an exhibition featuring solutions for pharma and biotech.

There is a registration fee to attend the conferences. To visit the exhibition is free.